Application 210329
- Type
- ANDA
- Sponsor
- JUBILANT GENERICS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TADALAFIL | TADALAFIL | TABLET;ORAL | 2.5MG | No | No |
| 002 | TADALAFIL | TADALAFIL | TABLET;ORAL | 5MG | No | No |
| 003 | TADALAFIL | TADALAFIL | TABLET;ORAL | 10MG | No | No |
| 004 | TADALAFIL | TADALAFIL | TABLET;ORAL | 20MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210329-001 | TADALAFIL | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2026-05-15 | |
| A210329-002 | TADALAFIL | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2026-05-15 | |
| A210329-003 | TADALAFIL | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2026-05-15 | |
| A210329-004 | TADALAFIL | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2026-05-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A210329-001 | AB1 |
| A210329-002 | AB1 |
| A210329-003 | AB1 |
| A210329-004 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A210329-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2026-05-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A210329-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2026-05-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A210329-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2026-05-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A210329-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2026-05-15 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A210329-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2026-05-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A210329-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2026-05-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A210329-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2026-05-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A210329-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2026-05-15 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2026-05-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2026-05-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2026-05-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2026-05-15 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A210329-001 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A210329-002 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A210329-003 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A210329-004 | AB1 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A210329-001 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A210329-002 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A210329-003 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A210329-004 | AB1 | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-001 | AB1 | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-002 | AB1 | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-003 | AB1 | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-004 | AB1 | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tadalafil | TADALAFIL | Sun Pharmaceutical Industries, Inc. | 168a135b-1454-4def-9b03-c9a470bfcb5f | 2023-10-10 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Aphena Pharma Solutions - Tennessee, LLC | 6213fd38-9580-4253-91d2-14c28a711c20 | 2023-08-28 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| ALYQ | TADALAFIL | Teva Pharmaceuticals, Inc. | 2faa7a55-3054-456b-8465-6ea6dc1c0aa9 | 2023-04-01 | Warnings, Adverse reactions | TADALAFIL |
| Tadalafil | TADALAFIL | Asclemed USA, Inc. | 5ea24573-2d16-40d8-a46c-7b5fa8669e69 | 2023-03-28 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Asclemed USA, Inc. | 30ae58ed-5b56-4513-8eb3-eb4f89b78f9d | 2023-03-22 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | ANI Pharmaceuticals, Inc. | 1dace1e7-c617-492f-bb0d-141bf4e673db | 2023-03-08 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Proficient Rx LP | aa345972-40b4-415e-acb5-31b808a8d815 | 2023-03-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| tadalafil | TADALAFIL | Proficient Rx LP | ac93704f-8e33-43ba-8b56-3d61092ff1d9 | 2023-01-01 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| tadalafil | TADALAFIL | Burel Pharmaceuticals, LLC | a2e7f393-5cfc-45e5-b87d-9e8abc8e4355 | 2022-12-01 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Proficient Rx LP | 7a105ef9-7129-4ce1-bd8d-ae316bf348e2 | 2022-11-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| TADLIQ | TADALAFIL | CMP Pharma, Inc. | 7a909b25-3772-403e-a5fe-e4a040293fb7 | 2022-10-15 | Warnings, Adverse reactions | TADALAFIL |
| Tadalafil | TADALAFIL | Macleods Pharmaceuticals Limited | 93dd604f-8f38-4600-afe8-0fcc92fd2497 | 2022-09-27 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Proficient Rx LP | b539e862-d5d4-4989-a3dd-1eba66285d53 | 2022-05-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Proficient Rx LP | 31c05a53-7282-46d0-81bd-108defe6fb38 | 2022-04-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Proficient Rx LP | 6fa9d4fa-86c9-4791-b28b-78e8b9341cea | 2022-04-01 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Asclemed USA, Inc. | aba646fe-70c2-1abb-e053-2995a90aa16d | 2022-01-28 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Qilu Pharmaceutical Co., Ltd. | f295f164-78fb-4224-b319-9f20b7a453b5 | 2021-11-17 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| tadalafil | TADALAFIL | VKT Pharma Private Limited | b4d9851c-5c06-4532-bd82-16d92b60c28f | 2021-11-17 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Cipla USA Inc. | cf6fc925-ad20-4ed0-9356-15d24afa8d0b | 2020-10-21 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Aphena Pharma Solutions - Tennessee, LLC | 36350106-98bc-41fc-bede-8be5e6f54a8a | 2020-10-02 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.